Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Tumour evolution inferred by single-cell sequencing.

Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, Cook K, Stepansky A, Levy D, Esposito D, Muthuswamy L, Krasnitz A, McCombie WR, Hicks J, Wigler M.

Nature. 2011 Apr 7;472(7341):90-4. doi: 10.1038/nature09807. Epub 2011 Mar 13.

2.

Genomic complexity of multiple myeloma and its clinical implications.

Manier S, Salem KZ, Park J, Landau DA, Getz G, Ghobrial IM.

Nat Rev Clin Oncol. 2017 Feb;14(2):100-113. doi: 10.1038/nrclinonc.2016.122. Epub 2016 Aug 17. Review.

PMID:
27531699
3.

Genomic tumor evolution of breast cancer.

Sato F, Saji S, Toi M.

Breast Cancer. 2016 Jan;23(1):4-11. doi: 10.1007/s12282-015-0617-8. Epub 2015 May 22. Review.

PMID:
25998191
5.

Cancer systems biology in the genome sequencing era: part 1, dissecting and modeling of tumor clones and their networks.

Wang E, Zou J, Zaman N, Beitel LK, Trifiro M, Paliouras M.

Semin Cancer Biol. 2013 Aug;23(4):279-85. doi: 10.1016/j.semcancer.2013.06.002. Epub 2013 Jun 19. Review.

PMID:
23791722
6.

Cancer systems biology in the genome sequencing era: part 2, evolutionary dynamics of tumor clonal networks and drug resistance.

Wang E, Zou J, Zaman N, Beitel LK, Trifiro M, Paliouras M.

Semin Cancer Biol. 2013 Aug;23(4):286-92. doi: 10.1016/j.semcancer.2013.06.001. Epub 2013 Jun 18. Review.

PMID:
23792107
7.

Dissecting cancer evolution at the macro-heterogeneity and micro-heterogeneity scale.

Barber LJ, Davies MN, Gerlinger M.

Curr Opin Genet Dev. 2015 Feb;30:1-6. doi: 10.1016/j.gde.2014.12.001. Epub 2014 Dec 31. Review.

8.

Tumour Heterogeneity: The Key Advantages of Single-Cell Analysis.

Tellez-Gabriel M, Ory B, Lamoureux F, Heymann MF, Heymann D.

Int J Mol Sci. 2016 Dec 20;17(12). pii: E2142. doi: 10.3390/ijms17122142. Review.

9.

Circulating tumour cells: insights into tumour heterogeneity.

Hayes DF, Paoletti C.

J Intern Med. 2013 Aug;274(2):137-43. doi: 10.1111/joim.12047. Review.

10.

Application of single-cell genomics in cancer: promise and challenges.

Wills QF, Mead AJ.

Hum Mol Genet. 2015 Oct 15;24(R1):R74-84. doi: 10.1093/hmg/ddv235. Epub 2015 Jun 25. Review.

11.

A new branch on the tree: next-generation sequencing in the study of cancer evolution.

Brosnan JA, Iacobuzio-Donahue CA.

Semin Cell Dev Biol. 2012 Apr;23(2):237-42. doi: 10.1016/j.semcdb.2011.12.008. Epub 2012 Jan 8. Review.

12.

Single-Cell Sequencing Technology in Oncology: Applications for Clinical Therapies and Research.

Ye B, Gao Q, Zeng Z, Stary CM, Jian Z, Xiong X, Gu L.

Anal Cell Pathol (Amst). 2016;2016:9369240. doi: 10.1155/2016/9369240. Epub 2016 May 25. Review.

13.

Tumour heterogeneity and immune-modulation.

Jamal-Hanjani M, Thanopoulou E, Peggs KS, Quezada SA, Swanton C.

Curr Opin Pharmacol. 2013 Aug;13(4):497-503. doi: 10.1016/j.coph.2013.04.006. Epub 2013 May 7. Review.

14.

Investigating intratumour heterogeneity by single-cell sequencing.

Ren SC, Qu M, Sun YH.

Asian J Androl. 2013 Nov;15(6):729-34. doi: 10.1038/aja.2013.106. Epub 2013 Oct 21. Review.

15.

Tumor Heterogeneity, Single-Cell Sequencing, and Drug Resistance.

Schmidt F, Efferth T.

Pharmaceuticals (Basel). 2016 Jun 16;9(2). pii: E33. doi: 10.3390/ph9020033. Review.

16.

Measuring cancer evolution from the genome.

Graham TA, Sottoriva A.

J Pathol. 2017 Jan;241(2):183-191. doi: 10.1002/path.4821. Epub 2016 Nov 18. Review.

PMID:
27741350
17.

Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis.

Ellsworth DL, Blackburn HL, Shriver CD, Rabizadeh S, Soon-Shiong P, Ellsworth RE.

Clin Transl Med. 2017 Dec;6(1):15. doi: 10.1186/s40169-017-0145-6. Epub 2017 Apr 12. Review.

Supplemental Content

Support Center